NEU 3.41% $16.71 neuren pharmaceuticals limited

Share Price, page-11776

  1. 6,025 Posts.
    lightbulb Created with Sketch. 19176
    Baldwidx

    My main reason for posting this was because we cannot keep stating as fact that Neuren engaged Jefferies either as a defence advisor or an adviser for finding a suitable buyer.

    Firstly, Neuren has never confirmed that Jefferies was engaged (nor did they deny it).

    Secondly, while The Australian reported on 17/11/24 that an advisory firm had recently been engaged by Neuren in response to “buyer interest from US-based industry giants”, Neuren flatly denied that their appointment of an advisory firm was in response to any approaches from third parties.

    Thirdly, while the report of a “defense adviser” being appointed is suggestive of an imminent hostile takeover threat, Neuren said it had simply appointed a “corporate and strategic adviser” several months before as a “normal step in Neuren’s ongoing growth and development”.

    What’s the truth? - I think one has to to accept that what Neuren has said in its announcement to the market is correct.

    However, I do note that Neuren’s advice on when the adviser was appointed suggests it happened around August 2023, shortly after the updated licence agreement with Acadia (including ROW rights) was announced, and I do wonder if that’s just coincidental timing.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$16.71
Change
-0.590(3.41%)
Mkt cap ! $2.135B
Open High Low Value Volume
$17.50 $17.55 $16.57 $10.01M 594.0K

Buyers (Bids)

No. Vol. Price($)
1 598 $16.70
 

Sellers (Offers)

Price($) Vol. No.
$16.87 1676 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.